Personalized Brain Cancer Vaccine May Help Against Aggressive Glioblastoma
discovermagazine - Discover how a personalized DNA vaccine trained patients’ immune systems to target their own tumors, with one participant remaining cancer-free nearly five years later.
AI Summary: A customized vaccine targeting each patient's tumor has demonstrated encouraging immune responses and signs of clinical benefit against aggressive glioblastoma. Researchers report enhanced T‑cell activity and preliminary survival signals, suggesting personalized neoantigen vaccines may help control this stubborn brain cancer and warrant larger, controlled trials to confirm impact.
- New models and datasets speeding brain tumor research (3)
- Next-gen glioblastoma immunotherapies: CAR T, drugs, stem cells (3)
- Personalized glioblastoma vaccine: early immune and survival signals (3)
- All Other Stories
New models and datasets speeding brain tumor research
Next-gen glioblastoma immunotherapies: CAR T, drugs, stem cells
Personalized glioblastoma vaccine: early immune and survival signals
All Other Stories
Related Stories
First‑in‑human glioblastoma immunotherapy yields promising PFS benefit / 9 hrs
Rogaratinib shows activity in SDH‑deficient GIST phase 2 trial / 6 wks
Genetic clues explain tagraxofusp resistance in rare leukemia (BPDCN) / 9 hrs
Adjuvant selpercatinib sharply cuts recurrence in RET‑fusion lung cancer / 5 wks
CRISPR CD33‑deleted allogeneic transplant shows early AML promise / 7 wks
Single‑cycle pembrolizumab yields striking responses in dMMR colon cancer / 2 months
EMERALD‑3 tests tremelimumab/durvalumab combos for embolisation‑eligible HCC / 7 days
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Behavioral Health, Pediatric Oncology, Alzheimer's disease, Gene Therapy and look for the RSS link.
StackHealth Time Machine